Inhibitor Therapeutics, Inc. Prepaid Expense and Other Assets, Current
Inhibitor Therapeutics, Inc. (INTI) had Prepaid Expense and Other Assets, Current of $71.05 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $71.05K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $84.97K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $71.51K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $87.43K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $71.05K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $84.97K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $71.51K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $87.43K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $92.03K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $99.11K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $87.80K 10-K · filed 2026-03-26 |
| 2024-09-30 | $73.14K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $74.63K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $112.40K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $109.24K 10-K · filed 2025-03-28 |
| 2022-12-31 | $23.90K 10-K · filed 2024-03-29 |
| 2015-09-30 | $56.61K 10-Q · filed 2015-11-04 |
| 2015-06-30 | $46.27K 10-Q · filed 2015-08-14 |
| 2014-12-31 | $97.82K 10-Q · filed 2015-11-04 |